MRD是急性淋巴性白血病(ALL)骨髓移植成敗關鍵！？〡ft.中國醫藥大學附設醫院內科部葉士芃副主任\u0026臺中榮民總醫院血液腫瘤科 滕傑林主任 〡【抗癌會診室】

(24:47)

【抗癌會診室】急性淋巴性白血病(ALL)治療成敗關鍵MRD! ?專家來解答〡ft.臺大醫院血液科周文堅主任\u0026林口長庚醫院血液科郭明宗主任〡

(23:46)

兒童不明原因發燒、淋巴結腫大、骨頭痛，小心是急性淋巴性白血病 ALL〡ft.馬偕兒童醫院 兒童血液腫瘤科 劉希哲醫師〡【抗癌攻略】

(15:32)

急性淋巴性白血病(ALL) 標靶免疫助攻 抗復發〡ft.成大醫院血液科 許雅婷醫師〡【抗癌攻略】

(15:3)

控制急性淋巴白血病 骨髓移植需達MRD陰性

(1:52)

EP7｜2023癌症論壇／急性淋巴性白血病 李啟誠：細胞治療精準滅癌

(13:6)

血癌難纏易復發 MRD搭配標靶藥延存活率

(1:38)

MRD negativity in ALL

(1:57)

The importance of MRD assessment in all phases of ALL treatment

(46)

The role of MRD in ALL: what defines a complete response?

(3:35)

Approaches to and the use of MRD in ALL

(5:17)

Importance of MRD monitoring in ALL

(1:46)

MRD in pediatric ALL: clinical evidence, treatment decisions \u0026 outcomes

(2:4)

Significance of MRD negativity in Ph-negative ALL

(1:1econd)

MRD-driven HSCT for ALL

(3:48)

Improving the use of MRD for the prognosis and treatment of ALL

(1:52)

The evolving landscape of ALL therapy and the impact of MRD

(15:2)

MRD \u0026 Me

(8:18)

What You Need to Know About MRD for AML: The Basics | Dr. Tian Zhang #AML

(1:2:16)